Biotech Values

[biomaven0]

this class of drugs works very well to retard tumor progression for some cancer subgroups, while at the same time significantly accelerating closely related tumors

I'd like to see more evidence for this claim. Showing that one subgroup does much better than another doesn't imply that the drug is actually making the inferior subgroup worse.

Peter